ES
Easwaran Sreekumar
Institute of Advanced Virology (IAV), Rajiv Gandhi Centre for Biotechnology, Indian Veterinary Research Institute, Institute of Animal Health and Veterinary Biologicals Palode
0000-0001-6345-3590
Employment
-
Institute of Advanced Virology (IAV) Director2021 - Present
-
Rajiv Gandhi Centre for Biotechnology Scientist2007 - Present
-
Rajiv Gandhi Centre for Biotechnology Scientist2004 - 2007
-
Institute of Animal Health and Veterinary Biologicals Palode Research Assistant2003 - 2004
-
Department of Animal Husbandry, Kerala Veterinary Surgeon1997 - 1998
Education
-
Rajiv Gandhi Centre for Biotechnology PhD1998 - 2004
-
Indian Veterinary Research Institute MVSc1994 - 1996
-
College of Veterinary and Animal Sciences Mannuthy BVSc & AH1988 - 1994
Projects & Funding
Projects & funding information is unavailable.
Publications (16)
- Cell type-dependent induction of type I interferon and PARP1 activation in astrocytes and neurons during chikungunya virus infection Save
- Synthesis and Anti‐Dengue Virus Activity of 2‐Aza‐Indolizidines Derived From D‐Glucose Save
- Utility of Recombinant Envelope Domain III as a Diagnostic Antigen for the Specific Detection of Kyasanur Forest Disease Save
- Ponatinib and other clinically approved inhibitors of Src and Rho-A kinases abrogate dengue virus serotype 2- induced endothelial permeability Save
- Rabies vaccine response in companion animals: Comparative evaluation of VSV-based pseudovirion neutralization test (PVNT) and rapid fluorescent focus inhibition test (RFFIT) Save
- Assessing anti-rabies vaccine response in humans: A rapid and high-throughput adaptable, pseudovirus-based neutralization assay as an alternative to rapid fluorescent focus inhibition test (RFFIT) Save
- Reproducible generation of Nipah virus pseudovirions with uniform expression of F and G surface glycoproteins for high-throughput neutralization assays Save
- Human bocavirus infections in paediatric patients in a tertiary care hospital in Kerala, India Save
- Ponatinib and other clinically approved inhibitors of Src and Rho-A kinasesabrogate dengue virus serotype 2- induced endothelial permeability Save
- Fingolimod (FTY720), an FDA‐approved sphingosine 1‐phosphate (S1P) receptor agonist, restores endothelial hyperpermeability in cellular and animal models of dengue virus serotype 2 infection Save